One molecule, eight Medicare prices, one cash price

Medicare Part B pays $2.35 to $13.15 per milligram of ustekinumab depending on which label is on the syringe. Two biosimilars cost Medicare more than the drug they copy. This analysis prices all 101 US biosimilars against their reference product, and publishes on September 23.

A new analysis publishes every Wednesday. The full schedule is on the index.